Delivery Order SPE2DB24D3015-SPE2DB25FGANQ
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $3,789.82 to AmerisourceBergen Drug Corp for the supply of Aplenzin ER 174 mg tablets (30-count packaging) on August 4, 2025, with completion scheduled for August 5, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (designated SPE2DX), valued at $999,999,999.00 and...
- The Defense Logistics Agency Troop Support Medical awarded a firm fixed price delivery order valued at approximately $8,295 to Amerisourcebergen Drug Corporation for the supply of 348 mg APLENZIN ER tablets. The prime contractor will deliver 30 tablets to a facility located in Conshohocken, Pennsylvania by July 31, 2023 in fulfillment of this order issued under an existing indefinite-delivery/indefinite-quantity contract vehicle. No subcontractors or set aside designations were identified. The...
- The Defense Logistics Agency Troop Support Medical awarded a firm fixed price delivery order valued at $2,940.29 to Amerisourcebergen Drug Corporation for 348 mg Aplenzin ER tablets. Amerisourcebergen Drug Corporation, a division of Amerisourcebergen Corporation, will deliver the pharmaceutical products to a location in Conshohocken, Pennsylvania by July 11, 2023 in accordance with the terms set forth in the contract. As the Defense Logistics Agency is responsible for worldwide logistics support...
- This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $14,165.95 firm fixed-price delivery order is for the medical product "APLENZIN ER 348 MG TABLET 30S" and has a performance period through May 2, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of APLENZIN ER 174 MG TABLET 30S, a pharmaceutical product, with a ceiling value of $26,982.26. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of February 18, 2025. AmerisourceBergen holds a significant Indefinite Delivery...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $6,162.59 firm fixed-price contract is for the delivery of APLENZIN ER 522 MG TABLET 30S, a prescription medication. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, which provides a comprehensive range of pharmaceutical products...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $32,576.82 firm fixed-price delivery order is for the supply of Aplenzin ER 522 mg tablets, a medication used to treat depression. The award is not set-aside and is part of a larger Indefinite Delivery Contract (IDC) vehicle, designated as SPE2DX, valued at $999,999,999.00. This IDC provides a comprehensive global...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $34,315.44 firm fixed-price contract is for the supply of APLENZIN ER 522 MG TABLET 30S, a prescription medication, with a performance period ending on May 17, 2023. The contract is not designated as a set-aside. Amerisourcebergen holds a significant $999,999,999 Indefinite...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for ORSERDU 345 mg tablets in a 30-count package. This competitively awarded, firm fixed-price delivery order carries a ceiling value of $27,841.82 with an ultimate completion date of August 11, 2025. The contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at $999,999,999.00 and...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a firm fixed-price delivery order valued at $33,210.08 to AmerisourceBergen Drug Corp on August 18, 2025, with an ultimate completion date of August 19, 2025. This non-set-aside contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. AmerisourceBergen Drug Corp,...
- SPE2DB24D3015Indefinite Delivery Contract
- SPE2DB24D3015-SPE2DB25FGANQDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $9,747.73 to AmerisourceBergen Drug Corp for the supply of Aplenzin ER 348 mg tablets (30-count units) on August 13, 2025, with an ultimate completion date of August 14, 2025. This firm fixed-price, competitively awarded delivery order was issued with no set-aside designation and specifies performance at the vendor's Conshohocken, Pennsylvania location. The contract represents a child delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical vendor for federal medical procurement supporting military and veteran healthcare systems. The company's comprehensive SPE2DX contract vehicle enables supply of a wide range of pharmaceutical products and medical supplies, including specialty medications, vaccines, and medical devices across multiple therapeutic domains. This delivery order for Aplenzin ER, a medication used in neurological and psychiatric treatment, exemplifies the company's role in fulfilling routine pharmaceutical supply requirements for the Defense Health Agency and other federal healthcare customers through the DLA's Medical Supply Chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $9.7k | 8/13/25 |